Lung cancer stem cells: Tools and targets to fight lung cancer

Oncogene

Volumn 29, Issue 33, 2010, Pages 4625-4635

  Eramo, A ^a   Haas, T L ^a,b   De Maria, R ^a,b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b Mediterranean Institute of Oncology   (Italy)

Author keywords

cancer stem cells; lung cancer; stem cells; therapy

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; K RAS PROTEIN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P27; TRANSCRIPTION FACTOR SOX2;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RISK; CANCER STEM CELL; CARCINOGENESIS; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; TREATMENT RESPONSE; ANIMAL; LUNG NEOPLASMS; PATHOLOGY;

ANIMALS; HUMANS; LUNG NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 77955922601     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.207     Document Type: Review

References (103)

1. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. (2009). Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11: R46.
2. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
3. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
4. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M et al. (2009). Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
5. Barker N, van de Wetering M, Clevers H. (2008). The intestinal stem cell. Genes Dev22: 1856-1864.
6. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ et al. (2007). CD133(+) and CD133(\) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015.
7. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L et al. (2009). Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106: 16281-16286.
8. Besson A, Hwang HC, Cicero S, Donovan SL, Gurian-West M, Johnson D et al. (2007). Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev 21: 1731-1746.
9. Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P et al. (2001). Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 98: 13790-13795.
10. Bianchi F, Nicassio F, Di Fiore PP. (2008). Unbiased vs biased approaches to the identification of cancer signatures: the case of lung cancer. Cell Cycle 7: 729-734.
11. Blau HM, Brazelton TR, Weimann JM. (2001). The evolving concept of a stem cell: entity or function? Cell 105: 829-841.
12. Blenkinsopp WK. (1967). Proliferation of respiratory tract epithelium in the rat. Exp Cell Res 46: 144-154.
13. Bonnet D, Dick JE. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hemato-poietic cell. Nat Med 3: 730-737.
14. Borczuk AC, Toonkel RL, Powell CA. (2009). Genomics of lung cancer. Proc Am Thorac Soc 6: 152-158.
15. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, Hamner B et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
16. Chen Y, Chan VS, Zheng B, Chan KY, Xu X, To LY et al. (2007). A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J Exp Med 204: 2529-2536.
17. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY et al. (2008). Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3: e2637.
18. Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, Giulini B et al. (2009). The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138: 1083-1095.
19. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL et al. (2006). Cancer stem cells\perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344.
20. Collins LG, Haines C, Perkel R, Enck RE. (2007). Lung cancer: diagnosis and management. Am Fam Physician 75: 56-63.
21. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A et al. (2009). Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106: 13820-13825.
22. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW et al. (2007). Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104: 10158-10163.
23. Dubey S, Powell CA. (2008). Update in lung cancer 2007. Am J Respir Crit Care Med 177: 941-946.
24. Dubey S, Powell CA. (2009). Update in lung cancer 2008. Am J Respir Crit Care Med 179: 860-868.
25. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L et al. (2008). Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One 3: e2428.
26. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A et al. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514.
27. Fuchs E. (2009). The tortoise and the hair: slow-cycling cells in the stem cell race. Cell 137: 811-819.
28. Giangreco A, Arwert EN, Rosewell IR, Snyder J, Watt FM, Stripp BR. (2009). Stem cells are dispensable for lung homeostasis but restore airways after injury. Proc Natl Acad Sci USA 106: 9286-9291.
29. Giangreco A, Groot KR, Janes SM. (2007). Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med 175: 547-553.
30. Giangreco A, Reynolds SD, Stripp BR. (2002). Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 161: 173-182.
31. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
32. Guan Y, Gerhard B, Hogge DE. (2003). Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 101: 3142-3149.
33. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA et al. (2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659.
34. Hill RP. (2006). Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66: 1891-1895.
35. Ho MM, Ng AV, Lam S, Hung JY. (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833.
36. Holyoake T, Jiang X, Eaves C, Eaves A. (1999). Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 94: 2056-2064.
37. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR. (2004a). Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 164: 577-588.
38. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR. (2004b). in vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations. Am J Physiol Lung Cell Mol Physiol 286: L643-L649.
39. Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S. (2008). Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 68: 6533-6540.
40. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H et al. (2009). Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-3389.
41. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S et al. (2007). Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol 25: 1315-1321.
42. Iwasaki H, Akashi K. (2007). Myeloid lineage commitment from the hematopoietic stem cell. Immunity 26: 726-740.
43. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R et al. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 15: 3243-3248.
44. Janne PA, Engelman JA, Johnson BE. (2005). Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol 23: 3227-3234.
45. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM et al. (2008). Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100: 1672-1694.
46. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L et al. (2009). Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7: 330-338.
47. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. (2006). Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12: 1167-1174.
48. Jin L, Lee EM, Ramshaw HS, Busfield SJ, Peoppl AG, Wilkinson L et al. (2009). Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell 5: 31-42.
49. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S et al. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
50. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L et al. (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 101: 4966-4971.
51. Lantuejoul S, Salameire D, Salon C, Brambilla E. (2009). Pulmonary preneoplasia\sequential molecular carcinogenetic events. Histo-pathology 54: 43-54.
52. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
53. Lee A, Kessler JD, Read TA, Kaiser C, Corbeil D, Huttner WB et al. (2005). Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci 8: 723-729.
54. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. (2008). Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 3: e3077.
55. Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF et al. (2008). Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679.
56. Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, Wu TJ et al. (2006). Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci USA 103: 9530-9535.
57. Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M et al. (2008). CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 98: 1389-1397.
58. Mahvi D, Bank H, Harley R. (1977). Morphology of a naphthalene-induced bronchiolar lesion. Am J Pathol 86: 558-572.
59. Minna JD, Roth JA, Gazdar AF. (2002). Focus on lung cancer. Cancer Cell 1: 49-52.
60. O'Brien CA, Pollett A, Gallinger S, Dick JE. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110.
61. Orkin SH, Zon LI. (2002). Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat Immunol 3: 323-328.
62. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, Todaro M et al. (2008). Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14: 8205-8212.
63. Pantel K, Alix-Panabieres C, Riethdorf S. (2009). Cancer micro-metastases. Nat Rev Clin Oncol 6: 339-351.
64. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I et al. (2004). EGF receptor gene mutations are common in lung cancers from 'never smokers' and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101: 13306-13311.
65. Pao W, Wang TY, Riely GJ, Miller VA, Pan Q, Ladanyi M et al. (2005). KRAS mutations and primary resistance of lung adeno-carcinomas to gefitinib or erlotinib. PLoS Med 2: e17.
66. Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S et al. (2010). Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140: 62-73.
67. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G et al. (2006). Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765.
68. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, Russell R et al. (2009). Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: 568-580.
69. Rawlins EL. (2008). Lung epithelial progenitor cells: lessons from development. Proc Am Thorac Soc 5: 675-681.
70. Rawlins EL, Okubo T, Xue Y, Brass DM, Auten RL, Hasegawa H et al. (2009). The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4: 525-534.
71. Reya T, Morrison SJ, Clarke MF, Weissman IL. (2001). Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
72. Reynolds BA, Weiss S. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710.
73. Reynolds SD, Giangreco A, Power JH, Stripp BR. (2000). Neuro-epithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 156: 269-278.
74. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115.
75. Riely GJ, Marks J, Pao W. (2009). KRAS mutations in non-small cell lung cancer. Proc Am Thorac Soc 6: 201-205.
76. Ross JS, Slodkowska EA. (2009). Circulating and disseminated tumor cells in the management of breast cancer. Am J Clin Pathol 132: 237-245.
77. Scagliotti G, Hanna N, Fossella F, Sugarman K, Blatter J, Peterson P et al. (2009). The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies. Oncologist 14: 253-263.
78. Schatton T, Frank NY, Frank MH. (2009). Identification and targeting of cancer stem cells. Bioessays 31: 1038-1049.
79. Sekido Y, Fong KM, Minna JD. (2003). Molecular genetics of lung cancer. Annu Rev Med 54: 73-87.
80. Sholl LM, Long KB, Hornick JL. (2009). Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol 18: 55-61.
81. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al. (2005). Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174: 6477-6489.
82. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828.
83. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T et al. (2004). Identification of human brain tumour initiating cells. Nature 432: 396-401.
84. Song W, Li H, Tao K, Li R, Song Z, Zhao Q et al. (2008). Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract 62: 1212-1218.
85. Storms RW, Trujillo AP, Springer JB, Shah L, Colvin OM, Ludeman SM et al. (1999). Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci USA 96: 9118-9123.
86. Stripp BR, Maxson K, Mera R, Singh G. (1995). Plasticity of airway cell proliferation and gene expression after acute naphthalene injury. Am J Physiol 269: L791-L799.
87. Stripp BR, Reynolds SD. (2008). Maintenance and repair of the bronchiolar epithelium. Proc Am Thorac Soc 5: 328-333.
88. Theodoropoulos PA, Polioudaki H, Agelaki S, Kallergi G, Saridaki Z, Mavroudis D et al. (2009). Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett. 288: 99-106.
89. Tiseo M, Bartolotti M, Gelsomino F, Ardizzoni A. (2009). First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype. Expert Rev Anticancer Ther 9: 425-435.
90. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F et al. (2007). Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402.
91. Todaro M, Perez Alea M, Scopelliti A, Medema JP, Stassi G. (2008). IL-4-mediated drug resistance in colon cancer stem cells. Cell Cycle 7: 309-313.
92. Van Winkle LS, Buckpitt AR, Nishio SJ, Isaac JM, Plopper CG. (1995). Cellular response in naphthalene-induced Clara cell injury and bronchiolar epithelial repair in mice. Am J Physiol 269: L800-L818.
93. Ventura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C, Barbacid M et al. (2007). p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 39: 750-758.
94. Visvader JE, Lindeman GJ. (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
95. Wang JC, Dick JE. (2005). Cancer stem cells: lessons from leukemia. Trends Cell Biol 15: 494-501.
96. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. (2003). Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422: 313-317.
97. Yanagi S, Kishimoto H, Kawahara K, Sasaki T, Sasaki M, Nishio M et al. (2007). Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest 117: 2929-2940.
98. Yang ZJ, Ellis T, Markant SL, Read TA, Kessler JD, Bourboulas M et al. (2008). Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells. Cancer Cell 14: 135-145.
99. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C et al. (2007). Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123.
100. Zeng Z, Shi YX, Samudio IJ, Wang RY, Ling X, Frolova O et al. (2009). Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood 113: 6215-6224.
101. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N et al. (2008). Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14: 123-129.
102. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. (2009). Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8: 806-823.
103. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, Bayazitov IT et al. (2009). Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457: 603-607.